Ran Lu
Impact in
- Drug Discovery top 2%
- Physiology top 5%
- Adenosine and Purinergic Signaling
Papers in
- Rheumatology 10
- Systemic Lupus Erythematosus Research 8
-
- Adenosine and Purinergic Signaling 4
- Co-authors
- Lunzhao Yi (2 shared papers)Xianming Mo (13 shared papers)Jiamiao Liu (1 shared paper)Zhifang Sun (1 shared paper)Li Dang (1 shared paper)Tao Tang (1 shared paper)Honghui Yao (1 shared paper)Jun Zheng (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (3 papers)ImmunoHorizons (3 papers)Frontiers in Immunology (3 papers)Scientific Reports (2 papers)Signal Transduction and Targeted Therapy (2 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Ran Lu
55 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Drug Discovery 20
- Physiology 72
- Biomaterials 169
- Molecular Medicine 75
- Rehabilitation 53
Countries citing papers authored by Ran Lu
This map shows the geographic impact of Ran Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Lu more than expected).
Fields of papers citing papers by Ran Lu
This network shows the impact of papers produced by Ran Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Lu. The network helps show where Ran Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 360 | |
| 2 | 2017 | 107 | |
| 3 | 2018 | 60 | |
| 4 | 2013 | 58 | |
| 5 | 2023 | 48 | |
| 6 | 2018 | 43 | |
| 7 | 2017 | 36 | |
| 8 | 2016 | 30 | |
| 9 | 2021 | 29 | |
| 10 | 2017 | 28 | |
| 11 | 2019 | 27 | |
| 12 | 2019 | 26 | |
| 13 | 2025 | 25 | |
| 14 | 2016 | 24 | |
| 15 | 2019 | 23 | |
| 16 | 2019 | 23 | |
| 17 | 2024 | 22 | |
| 18 | 2021 | 20 | |
| 19 | 2016 | 19 | |
| 20 | 2021 | 19 |
About Ran Lu
Ran Lu is a scholar working on Rheumatology, Physiology, Immunology, Cancer Research and Molecular Biology, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (8 papers), Cancer Cells and Metastasis (5 papers), MicroRNA in disease regulation (5 papers), Adenosine and Purinergic Signaling (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Nanoplatforms for cancer theranostics (3 papers), Bone Tissue Engineering Materials (2 papers) and Developmental Biology and Gene Regulation (2 papers). The work is most often cited by research in Drug Discovery (20 citations), Physiology (72 citations), Biomaterials (169 citations), Molecular Medicine (75 citations) and Rehabilitation (53 citations). Ran Lu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Lunzhao Yi, Xianming Mo, Jiamiao Liu, Zhifang Sun, Li Dang, Tao Tang, Honghui Yao, Jun Zheng, Piao Zheng and Rong Fan. Their work appears in journals such as European Journal of Medicinal Chemistry, ImmunoHorizons, Frontiers in Immunology, Scientific Reports and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.